Sensorion SA

Research Sensorion SA (ALSEN) on Bullrun: market cap EUR 119.41M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALSEN
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 119.41M
• Financial periodFY2025
• Net income-EUR 29.43M
• Free cash flow-EUR 28.04M

Valuation Snapshot

latest market cap is EUR 119.41M.

About Sensorion SA

Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies.

Frequently asked questions

What is Sensorion SA's market cap?

Sensorion SA's market capitalization is EUR 119.41M.

What does Sensorion SA do?

Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France.